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Background: Pure interstitial duplications of chromosome band 4p16.3 represent an infrequent chromosomal
finding with, to the best of our knowledge, only two patients to date reported.
Case presentation: We report on a 13-year-old boy showing a set of dysmorphic facial features, attention deficit
hyperactivity disorders, learning difficulties, speech and cognitive delays, overgrowth and musculoskeletal anomalies
in whom an interstitial duplication of about 400 kb in 4p16.3 was detected by SNP-array analysis. The duplication
includes the complete coding sequence of FAM53A, SLBP, TMEM129 and TACC3 genes and the first exon of the FGFR3
gene. Phenotypic comparison with previously described patients harboring a microduplication of similar size and
position contributes to better define the clinical correlation of 4p16.3 microduplications, suggesting the existence of a
novel distinct and phenotypically recognizable syndrome. In addition, being the duplication identified in our case the
smallest so far reported, it allowed us to refine the smallest region of overlap among patients to 222 kb, enabling a
more accurate genotype-phenotype correlation for 4p16.3 microduplications.
Conclusions: Our case report provide clinical and molecular evidences supporting the existence of a novel 4p16.3
microduplication syndrome. The genes FAM53A, TACC3 and FGFR3 seems to play a key role in the etiology of the
clinical phenotype. Interestingly, our patient is the oldest described so far and for this reason useful to delineate the
long-term prognosis of these patients.
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Small (<1 Mb in size) and pure interstitial microduplica-
tions of the distal short arm of chromosome 4 are rare;
to the best of our knowledge, only two patients have
been to date reported. Some years ago, Hannes et al. [1]
described a 23-month-old boy whit neurodevelopmental
delay, seizures, glaucoma of the left eye and dysmorphic
features in whom a de novo submicroscopic (560 kb)
duplication of 4p involving the Wolf-Hirschhorn critical
region (WHSCR) has been identified. Later, Cyr at al. [2]
using a high-density oligonucleotide microarray de-
scribed the first patient carriers of a de novo 506 kb
microduplication in 4p16.3, distal to WHSCR, showing* Correspondence: m.carella@operapadrepio.it
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unless otherwise stated.developmental delay, seizures, macrocephaly, unilateral
glaucoma, abnormal hands and dysmorphic features.
In this study, we report an additional patient with the
smallest overlapping duplication in 4p16.3, detected by
SNP-array analysis, not including the WHSCR delineat-
ing the duplications’ phenotype. In addition, refinement
of the smallest region of overlap (SRO) to 222 kb high-
lights interesting genes as candidates for the common
observed clinical features, suggesting that the duplica-
tion in 4p16.3, distal to WHSCR, may represent a novel
clinically recognizable condition.Case presentation
Case report
The male patient was referred for the first time at the age
of 10 years for evaluation of autistic features, learningal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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are available on family history since he was adopted. Phys-
ical examination at 13 years of age revealed auxological
parameters above the average (weight >97th centile; height
between the 90th and 97th centile) and dysmorphic fea-
tures including high forehead with frontal bossing, small
palpebral fissures, epicanthal folds, hypertelorism (>2 SD),
dental abnormalities, high arched palate, micrognathia,
short neck (Figure 1). In addition, hyperopia and skeletal
anomalies (scoliosis), gynecomastia and bilateral pes pla-
nus were reported.
Neuropsychiatric evaluation showed speech delay, mild
cognitive impairment (QI 68), attention deficit hyperactiv-
ity disorder (ADHD). Also, the patient showed walking ab-
normalities (uncertain gait), clumsiness.
Abdominal ultrasound examination and brain mag-
netic resonance imaging (MRI) were normal. Genetic
evaluation revealed a normal 46,XY karyotype while
DNA analysis for FMR-1 gene excluded the diagnosis of
fragile X (FRAXA) syndrome.
Results
SNP array analysis showed a 4p16.3 duplication of a
minimum size of 393 kb, from nucleotide nt 1,405,662
(first duplicated probe: CN_1080836) to nucleotide nt
1,798,461 (last duplicated probe: CN_1081687), and a
maximum size of 413 kb, from nucleotide nt 1,390,388
(last present probe before the duplication: CN_1069802)
to nucleotide 1,804,276 (first present probe after the du-
plication: SNP_A-2213611).
The duplicated region encompass the entire coding se-
quences of FAM53A, SLBP, TMEM129, TACC3 genes and
the 5′ end of the FGFR3 gene (data not shown). According
to the International System for Human Cytogenetic No-
menclature (ISCN) 2013, molecular karyotype of the pa-
tient was arr[hg19]4p16.3(1,405,662-1,798,461)×3. ThereFigure 1 The picture of the proband at the age of 13 years.were no other clinically significant genomic alterations
identified.
Discussion
We report on a 13-year-old boy with an interstitial
393 kb duplication on the short arm of chromosome 4
(4p16.3). To our knowledge, there are only two patients
reported in the literature carriers of a duplications simi-
lar in size and position to the one identified in our
patients [1,2]. The clinical phenotype of our patient,
similarities and differences with previously reported
cases are discussed in detail and summarized in Table 1
while the location of the duplications is shown in Figure 2.
The clinical features shared by all three individuals include
psychomotor and language delay, musculoskeletal anomal-
ies, eyes alterations as well as craniofacial anomalies (high
forehead, frontal bossing, epicanthal folds, hypertelorism/
abnormal palpebral fissures, short neck) suggesting that
the cryptic 4p16.3 duplications results in a novel recog-
nizable microduplication syndrome. Seizure, MRI anom-
alies, abnormal ears, high arched palate and growth
alterations (macrocephaly in the patient reported by Cyr
et al., overgrowth in our) are also significant issues in
these patients (2/3). Others phenotypes observed are
hypotonia in the patient reported by Hannes et al. [1],
mild intellectual disability and micrognathia in our case.
Some differences in clinical presentations among the
4p16.3 microduplicated patients could be explained by
the influence of the genetic background of the rest of the
genome and/or the variable size and gene content of the
rearrangements. These factors could have additional or
modifying influences on the clinical features.
At a molecular level the small size (393 kb) of the du-
plication we present here allowed us to identify the SRO
among the patients and focus our attention on interest-
ing candidate genes that could be associated to the com-
mon traits reported.
The minimal duplicated region shared by all three pa-
tients is about 222 kb (1,575,789-1,798,461 bp), has
never been reported as copy number polymorphism
(CNP) in the Database of Genomic Variant and encom-
pass the entire sequence of the genes FAM53A, SLBP,
TMEM129, TACC3 and the 5′ end of the FGFR3 gene.
Of these genes, FAM53A and TACC3 are the best candi-
date for the neurodevelopmental features because highly
expressed in the early embryonic central nervous system
(FAM53A) suggesting critical roles in the neuronal de-
velopment [3] or encoding a protein (TACC3) that con-
trols the genesis of neurons from radial glial progenitor
cells (RGCs) during cortical development [4]. In addition,
mutations of the murine Tacc3 leads to retarded growth,
apoptosis of hematopoietic stem cells and facial clefting
[5]. The apparent role in facial development makes this
gene of interest also for the craniofacial traits of the
Table 1 Summary of the clinical features of the patients with 4p16.3 duplication overlapping with our patient
Clinical features Present case Hannes et al. [1] Cyr et al. [2]
Sex and age at diagnosis M, 13 years M, 23 months M, 9 months
Weight >97th centile < 3rd centile 30th centile
Height 90-97th centile N.R. 30th centile
Head circumference 25th-50th centile N.R. >95th centile
Neurocognitive Mild ID (IQ 68) Unknown Unknown
Neurologic Delayed motor development
and speech
Delayed motor development and
speech, seizure, hypotonia
Delayed motor development, seizure
Neuropsychiatric ADHD N.R. Too young
MRI Normal Delayed myelinisation Dilatation of the lateral ventricles
Craniofacial
Macro/Microcephaly N.R. Unknown Macrocephaly
Forehead High High High
Frontal bossing + + +
Epicanthal folds + + +
Hypertelorism + - +
Abnormal palpebral fissures Narrow and long Narrow and long Downslanted
Nose Normal Normal Broad nasal root and short nasal bridge
Low set/abnormal ears Normal Low-set and dysmorphic Low-set and posteriorly rotated
Palate High arched High arched Normal
Micrognathia Present Absent Absent
Neck Short Short Short
Musculoskeletal Scoliosis, bilateral flatfoot Small hands and feet, malformations
of the right hand
N.R.
Others Hyperopia, dental abnormalities,
gynecomastia




+, present; −, absent; ID, intellectual disability; ADHD, attention deficit hyperactivity disorder; N.R., not reported.
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fected tissues are equivalent to those that are dysgenic in
the patients (i.e. the tissues derived from the fronto-nasal
mass). Although these evidences suggest that TACC3
could be responsible for the dysmorphic facial featuresFigure 2 Schematic representation of the 4p16.3 duplications in the p
genome browser 2009 assembly (GRCh37/hg19) [http://genome.ucsc.reported, functional studies, additional experimental and
clinical data are needed to corroborate our hypothesis.
Regarding the growth alterations and the musculoskel-
etal malformations the best candidate is the gene FGFR3
(fibroblast growth factor receptor 3) that is a regulatorresent and previously reported patients based on the UCSC
edu/].
Palumbo et al. Molecular Cytogenetics  (2015) 8:15 Page 4 of 5of bone growth. Mutations in this gene has been associ-
ated with at least ten human disorders where skeletal al-
terations represent the principal clinical presentations. It
is interesting to highlight the fact that the features con-
cerning the growth (overgrowth in our patient), or at
least some of its parameters (macrocephaly in the pa-
tient described by Cyr et al.), of patients with duplication
of FGFR3 are opposed to that of Wolf-Hirschhorn Syn-
drome (WHS; del4p16.3) patients (microcephaly, growth
retardation). This phenomenon supports the hypothesis
of mirror phenotypes resulting from reciprocal deletion/
duplication in chromosomal regions containing dosage
sensitive genes as described for other copy number vari-
ants (16q11.2, 7q11.23, 5q35) [6,7].
In all patients to date reported, eyes anomalies have
been documented such as glaucoma in the patient de-
scribed in the Hannes’ paper, the iris pigmentation- het-
erochromia reported by Cyr et al. and the hyperopia of
our patient. Since this clinical evidence, in agreement
with Cyr et al., we consider the 4p16.3 locus very import-
ant in ocular development although, at this time, we can-
not be able to explain the biological mechanism related to
4p16.3 trisomy underlying these alterations. Evaluation of
more patients is needed to clarify this point.
Our patient does not share the seizures that are
present in the other two individuals. In contrast to the
4p16.3 duplications described by Hannes et al. [1] and
Cyr et al. [2] the duplication identified in the present pa-
tient do not encompass the LETM1 gene supporting the
hypothesis that overexpression of this gene may results
in seizure [2].
Needs to be elucidated the involvement of the SLBP
and TMEM129 genes in the etiology of the phenotype in
patients with dup4p16.3. The first encodes an RNA-
binding protein that recognize a stem-loop structure in
3′ non-coding sequence of histone mRNAs essential for
maturational cleavage and efficient translation of the en-
code histone [8] while the function of the latter remains
to be explored. Their contribution to the phenotype, if
any, is unknown. Evaluation of additional patients with
well-characterized 4p16.3 duplication and/or point mu-
tations in this region will be useful to elucidate the role
of individual genes for the clinical presentations.
Of note, our patients is the only one in which a con-
sistent pattern of neurobehavioral features including
ADHD, has been documented. Since the other two pa-
tients are too young, we cannot exclude that they will
show behavioral alterations in the feature thus we sug-
gest a periodic neurobehavioral clinical evaluation in
4p16.3 microduplication carriers.
Conclusions
In conclusion, in this report we provide clinical and mo-
lecular evidences supporting the existence of a novel4p16.3 microduplication syndrome. The shared clinical
features between our patient and those in previous re-
ports include psychomotor and language delay, skeletal
anomalies and a particular pattern of facial dysmorph-
isms. Narrowing the SRO to include only five genes we
performed a more detailed genotype-phenotype correl-
ation suggesting the FAM53A, TACC3 and FGFR3 genes
as candidates for the clinical manifestation of this syn-
drome. Finally, being our patients the oldest reported so
far he provides detailed clinical and phenotype informa-
tions across the lifespan facilitating a more accurate gen-
etic counselling and anticipatory care.Methods
SNP array analysis
Total DNA was obtained from peripheral blood using
automated BioRobot EZ1 (Qiagen, Solna, Sweden). We
checked it for quantity and purity using the NanoDrop
ND-1000 Spectrophotometer (Thermo Fisher Scientific,
Wilmington, DE). Molecular karyotyping was performed
using the high-resolution Genome Wide Human SNP
Array 6.0 (Affymetrix, Santa Clara, CA) providing whole
genome coverage with a density of 1.8 million markers, in-
cluding 906,600 SNPs and 946,000 copy number markers.
Labeling, hybridization, washing, scanning and image ex-
traction were performed as previously described [9]. Copy
number variations (CNVs) identified in this study and
overlapping with annotated CNVs in Database of Genomic
Variants (DGV; http://dgv.tcag.ca/dgv/app/home), were
not considered. Furthermore, we filtered all CNVs that
had ≤50 contributing markers.Consent
We obtained written informed consent from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor of this journal.Abbreviations
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